NV QIAGEN
CIK 1015820 · last filed 2017-11-07
NV QIAGEN is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for HTGM, was dated Nov 7, 2017. Across all open-market trades the lifetime net is +$173.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $245.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$245.14M
2
9
$173.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | 10%+ Owner | — | $0.48 | — | $0 | 1 | 2017-11-07 |
| QGEN | 10%+ Owner | 6,614,705 | $37.06 | $245.14M | $173.4K | 8 | 2007-06-19 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-11-07 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Buy (P) | — | $0 | EDGAR |
| 2007-06-19 | QGEN | Buy (P) | +10,000 | $13.5K | EDGAR |
| 2007-06-14 | QGEN | Buy (P) | +10,000 | $12.9K | EDGAR |
| 2007-06-06 | QGEN | Buy (P) | +50,000 | $65.5K | EDGAR |
| 2007-06-04 | QGEN | Buy (P) | +5,000 | $6.5K | EDGAR |
| 2007-05-31 | QGEN | Buy (P) | +40,000 | $52.4K | EDGAR |
| 2007-05-25 | QGEN | Buy (P) | +17,500 | $22.6K | EDGAR |
| 2007-05-09 | QGEN | Mixed | +240,000 | $108.0K | EDGAR |
| 2007-05-03 | QGEN | Mixed | +340,000 | $153.0K | EDGAR |